Tsumura & Co. (TYO:4540)

Japan flag Japan · Delayed Price · Currency is JPY
3,930.00
-6.00 (-0.15%)
At close: Mar 6, 2026
-8.56%
Market Cap 292.96B
Revenue (ttm) 189.50B
Net Income (ttm) 29.01B
Shares Out 74.54M
EPS (ttm) 386.55
PE Ratio 10.17
Forward PE 11.01
Dividend 152.00 (3.87%)
Ex-Dividend Date Mar 30, 2026
Volume 360,600
Average Volume 396,575
Open 3,880.00
Previous Close 3,936.00
Day's Range 3,838.00 - 3,936.00
52-Week Range 3,306.00 - 4,515.00
Beta -0.07
RSI 39.38
Earnings Date May 8, 2026

About Tsumura & Co.

Tsumura & Co. engages in the production and sale of Kampo extract intermediates and granular Kampo formulations in Japan and internationally. The company offers products for female problems, proneness to fatigue, skin problems, gastrointestinal problems, obesity, constipation and hemorrhoids, as well as body aches, children's sickness, stress, urinary problems, and cold, cough, and nasal and throat inflammation symptoms. It also offers over-the-counter Kampo medicines. The company was founded in 1893 and is headquartered in Tokyo, Japan. [Read more]

Sector Healthcare
Founded 1893
Employees 4,272
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4540
Full Company Profile

Financial Performance

In fiscal year 2025, Tsumura & Co.'s revenue was 181.09 billion, an increase of 20.05% compared to the previous year's 150.85 billion. Earnings were 32.43 billion, an increase of 94.10%.

Financial Statements

News

There is no news available yet.